Entity usage

From MaRDI portal

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 5 results in range #1 to #5.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Adjusting Survival Analysis for the Presence of Unadjudicated Study Events: Label: en
  2. Issues in designing sequential stopping rules for monitoring side effects in clinical trials: Label: en
  3. Computations for Group Sequential Boundaries Using the Lan-DeMets Spending Function Method: Label: en
  4. Optimal two-stage designs for phase II clinical trials: Label: en
  5. Meta-analysis in clinical trials: Label: en

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://portal.mardi4nfdi.de/wiki/Special:EntityUsage/Q60781"
Powered by MediaWiki